THERESA GRASING: Open Payments
NPI 1245757103 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 62 payments from 26 companies in 2025. Trend: 2023 $1,217 · 2024 $1,300 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $255 |
| Amgen Inc. | 5 | $98 |
| SANOFI-AVENTIS U.S. LLC | 3 | $93 |
| Novo Nordisk Inc | 4 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Radius Health, Inc. | 3 | $68 |
| Tandem Diabetes Care, Inc. | 2 | $61 |
| Alexion Pharmaceuticals, Inc. | 3 | $58 |
| Insulet Corporation | 2 | $52 |
Products named: JARDIANCE, MOUNJARO, TZIELD, Kerendia, EVENITY, Tymlos, t:slim X2 Insulin Pump with Control-IQ, STRENSIQ.
Industry payments across MD — which companies pay providers there.
